CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

New SLE Guideline Aims to Improve Diagnosis, Reduce Steroids

Published: Tue, 17 Oct 2017 08:26:29 EDT
The British Society for Rheumatology issued the first comprehensive guideline for management of systemic lupus erythematosus in adults.
Medscape Medical News

EHR Work Measures Proposed to Address Burnout

Published: Tue, 17 Oct 2017 08:16:06 EDT
Commentary in Annals of Internal Medicine suggests vendors imbed metrics to measure extra work created by EHRs.
Medscape Medical News

Weight Watchers Successful Part of Diabetes Prevention in UK

Published: Tue, 17 Oct 2017 07:39:07 EDT
A diabetes prevention program delivered in association with Weight Watchers in the UK led to a marked average weight reduction (10 kg) and a significant fall in HbA1c in people with prediabetes.
Medscape Medical News
Displaying results 13-15 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Impact bags $22M to save ex-Sanofi drug from trial limbo

Published: Fri, 13 Oct 2017 12:05:54 +0000
In 2013, Sanofi was running multiple clinical trials to establish fedratinib as the cornerstone of its oncology portfolio. Then, in the space of a week, the FDA ordered a clinical hold and Sanofi canned the JAK2 inhibitor. Now, members of the team who first developed fedratinib have brought it back from the dead.

Spark Therapeutics’ Luxturna advisory committee vote sets gene therapy landmark

Published: Fri, 13 Oct 2017 10:18:34 +0000
After decades of research, a gene therapy to correct a specific genetic mutation is on the brink of being approved by the FDA.

New stem cell type expands R&D, regenerative medicine possibilities

Published: Thu, 12 Oct 2017 14:00:13 +0000
Scientists from the Wellcome Trust Sanger Institute have created a new type of stem cell that retains the ability to develop into any type of cell. Derived from embryos in the earliest stage of development, these stem cells open the doors to disease research and the development of regenerative treatments.
Displaying results 13-15 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top